Atlas Trials

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Clinical trial NCT00502086 · COMPLETED

Trial details

NCT number
NCT00502086
Sponsor
Catalysis SL
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
CirrhosisChronic Hepatitis C
Start date
2005-05-01
Primary completion
2009-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.